Sexually dimorphic regulation of NK-1 receptor-mediated electrophysiological responses in vagal primary afferent neurons.
Neurons can display sexual dimorphism in receptor expression, neurotransmitter release, and synaptic plasticity. We have detected sexual dimorphism in functional tachykinin receptors in vagal afferents (nodose ganglion neurons, NGNs) by studying the effects of hormonal variation on the depolarizing actions of substance P (SP) in female guinea pig NGNs. Using conventional "sharp" microelectrode recording plus measurement of serum 17beta-estradiol values, we examined SP responses in NGNs isolated from 1) ovariectomized females (OVX), 2) OVX females treated with 17beta-estradiol (OVX + E2), 3) pregnant females, and 4) males. Depending on various manipulations, 19-41% female NGNs were depolarized (16 +/- 1.1 mV, mean +/- SE) by 100 nM SP acting through NK-1 receptors. The NGNs of OVX + E2 females (41%, 15/37; 17 +/- 2.1 mV) and pregnant females (41%, 32/79; 16 +/- 1.7 mV) were more likely to respond to SP than those of control males (P < 0.001). The percentage of SP-sensitive NGNs from OVX females (19%, 21/109; 15 +/- 1.9 mV) was not significantly different (P = 0.361) from that of control males (13%, 11/83; 13 +/- 2.0 mV). The serum 17beta-estradiol values for OVX + E2, pregnant, and OVX females were 23.9 +/- 3.3 pg/ml (n = 8), 16.0 +/- 2.4 pg/ml (n = 4), and 3.9 +/- 0.3 pg/ml (n = 8), respectively. These data indicate that there is a gender difference in NK-1 receptor expression in guinea pig nodose neurons, and they suggest that estrogen may modulate SP responsiveness in these neurons.
Oh
E J
EJ
Department of Pharmacology and Experimental Therapeutics, Gynecology, and Reproductive Science, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA.
Thompson
L P
LP
Weinreich
D
D
D000818:Animals; D001549:Benzamides / Q000494:pharmacology; D004594:Electrophysiology; D004958:Estradiol / Q000097:blood; D005260:Female; D012739:Gonadal Steroid Hormones / Q000494:pharmacology; D006168:Guinea Pigs; D008297:Male; D008564:Membrane Potentials / Q000187:drug effects / Q000502:physiology; D009475:Neurons, Afferent / Q000737:chemistry / Q000502:physiology*; D009620:Nodose Ganglion / Q000166:cytology* / Q000502:physiology; D009919:Orchiectomy; D010052:Ovariectomy; D010880:Piperidines / Q000494:pharmacology; D011247:Pregnancy; D011804:Quinolines / Q000494:pharmacology; D018040:Receptors, Neurokinin-1 / Q000502:physiology*; D012701:Serotonin / Q000494:pharmacology; D012727:Sex Characteristics; D013373:Substance P / Q000494:pharmacology; D013739:Testosterone / Q000494:pharmacology
D001549:Benzamides; D012739:Gonadal Steroid Hormones; D010880:Piperidines; D011804:Quinolines; D018040:Receptors, Neurokinin-1; C080755:3-(2-methoxybenzylamino)-2-phenylpiperidine; C106716:SB 223412; D012701:Serotonin; D013373:Substance P; D013739:Testosterone; D004958:Estradiol; C073839:SR 48968